<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04814745</url>
  </required_header>
  <id_info>
    <org_study_id>3236</org_study_id>
    <nct_id>NCT04814745</nct_id>
  </id_info>
  <brief_title>Intrathecal Morphine for Radical Robot Assisted Prostatectomy (TORNADO)</brief_title>
  <acronym>TORNADO</acronym>
  <official_title>Intrathecal Morphine Compared to Intravenous Tramadol and Transversus Abdominal Plane Block for Catheter Related Bladder Discomfort Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondazione Policlinico Universitario Agostino Gemelli IRCCS</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondazione Policlinico Universitario Agostino Gemelli IRCCS</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      investigators aim to compare the efficacy of intrathecal morphine, intravenous tramadol and&#xD;
      transversus abdominis plane block in the treatment of catheter related bladder discomfort&#xD;
      syndrome in patients scheduled for robotic assisted laparoscopic prostatectomy&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      patients scheduled for robot assisted laparoscopic prostatectomy will be treated depending on&#xD;
      the belonging group. In the morphine group patients will receive intrathecal morphine 0,15&#xD;
      mg; in the transversus abdominis plane block patients will receive ropivacaine 80 mg; in the&#xD;
      tramadol group patients will receive intravenous continuous infusion of tramadol 400 mg for&#xD;
      the first 24 hours postoperatively. All data will be collected in the post anesthesia room&#xD;
      and in the ward until the first post operative day.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 7, 2020</start_date>
  <completion_date type="Actual">February 1, 2021</completion_date>
  <primary_completion_date type="Actual">January 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>catheter related bladder discomfort syndrome</measure>
    <time_frame>immediately after surgery</time_frame>
    <description>grade 0 to III</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>pain relief</measure>
    <time_frame>immediately after surgery</time_frame>
    <description>assessment of post-operative pain by a 0 to 10 numeric rating score</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">33</enrollment>
  <condition>Catheter Related Complication</condition>
  <arm_group>
    <arm_group_label>morphine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>morphine 150 mcg will be administered intrathecally before surgery by using a 25 Gauge with acre spinal needle</description>
  </arm_group>
  <arm_group>
    <arm_group_label>tramadol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>tramadol 400 mg will be administered by using an elastomeric pump for 24 hours after surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ropivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>at the end of surgery transversus abdominis plane block will be performed bilaterally and ropivacaine 80 mg will be used</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>intrathecal infusion</intervention_name>
    <description>morphine 150 mcg will be used by intrathecal administration</description>
    <arm_group_label>morphine</arm_group_label>
    <other_name>morphine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intravenous Infusion</intervention_name>
    <description>tramadol administration</description>
    <arm_group_label>tramadol</arm_group_label>
    <other_name>tramadol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine injection</intervention_name>
    <description>bilateral transversus abdominis plane block by using ropivacaine 80 mg</description>
    <arm_group_label>ropivacaine</arm_group_label>
    <other_name>transversus abdominis plane lock</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  all patients scheduled for robotic assisted laparoscopic prostatectomy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  coagulation disorders and platelet dysfunction for spinal arm&#xD;
&#xD;
          -  obesity for transversus abdominis plane block arm&#xD;
&#xD;
          -  left ventricular ejection fraction &lt; 30%, end-stage renal disease and neurological&#xD;
             disorders for all groups&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Andrea</name>
      <address>
        <city>Roma</city>
        <state>Rome</state>
        <zip>00166</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>January 15, 2021</study_first_submitted>
  <study_first_submitted_qc>March 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 24, 2021</study_first_posted>
  <last_update_submitted>November 7, 2021</last_update_submitted>
  <last_update_submitted_qc>November 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Tramadol</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

